ENTEROCOCCAL AND VIRIDANS STREPTOCOCCAL INFECTIONS

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 1258-1288

  English, B Keith ^a,b   Shenep, Jerry L ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954329366     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50100-X     Document Type: Chapter

References (564)

1. W.E. Alborn Jr., N.E. Allen and D.A. Preston (1991) Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother. 35 2282-2287.
2. B. Alminrante, M. Tornos, M. Gurgui, et al. (1991) Prognosis of enterococcal endocarditis. Rev. Infect. Dis. 13 1248-1249.
3. D.M. Anastasiou, G.M. Thorne, S.A. Luperchio and J.D. Alder (2006) In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin-dalfopristin. Int. J. Antimicrob. Agents 28 385-388.
4. F.W. Andrewes and T.J. Horder (1906) A study of the streptococci pathogenic for man. Lancet 2 708-713.
5. D. Armstrong, H. Neu, L.R. Peterson, et al. (1995) The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s. Microb. Drug Resist. 1 1-4.
6. M. Arthur and P. Courvalin (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37 1563-1571.
7. S. Ashkenazi, S. Even-Tov, Z. Samra, et al. (1991) Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr. Infect. Dis. J. 10 742-746.
8. H.M. Babcock, D.J. Ritchie, E. Christiansen, et al. (2001) Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin. Infect. Dis. 32 1373-1375.
9. S.M. Bhavnani, J.A. Drake, A. Forrest, et al. (2000) A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn. Microbiol. Infect. Dis. 36 145-158.
10. E.H. Bingen, E. Denamur and N.Y. Lambert-Zechovsky (1991) Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J. Clin. Microbiol. 29 1888.
11. E. Bingen, N. Lambert-Zechousky, P. Mariane-Kurkdjian, et al. (1989) Bacteremia caused by a vancomycin-resistant enterococcus. Pediatr. Infect. Dis. J. 8 475-476.
12. M.C. Birmingham, C.R. Rayner, A.K. Meagher, et al. (2003) Linezolid for the treatment of multidrug-resistant, Gram-positive infections: Experience from a compassionate use program. Clin. Infect. Dis. 36 159-168.
13. A.L. Bisno, W.E. Dismukes, D.T. Durack, et al. (1989) Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. J. A. M. A. 261 1471-1477.
14. W.A. Bonadio (1993) Group D streptococcal bacteremia in children: Clin. Pediatr. (Phila.) 32 20-24.
15. M.G. Bonora, M. Ligozzi, A. Luzzani, et al. (2006) Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur. J. Clin. Microbiol. Infect. Dis. 25 197-198.
16. G.D. Bostic, M.B. Perri, L.A. Thal, et al. (1998) Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci. Diagn. Microbiol. Infect. Dis. 30 109-112.
17. J.M. Boulanger, E.L. Ford-Jones and A.G. Matlow (1991) Enterococcal bacteremia in a pediatric institution: A four year review. Rev. Infect. Dis. 13 847.
18. J.M. Boyce, S.M. Opal and J.W. Chow (1994) Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol. 32 1148-1153.
19. J.M. Boyce, S.M. Opal, G. Potter-Bynoe, et al. (1992) Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob. Agents Chemother. 36 1032-1039.
20. Brown, A.E., de Lancastre, H., and Henning, K., et al: Epidemic nosocomial vancomycin-resistant Enterococcus faecium (VREF) on a pediatric oncology unit. Presented at the 33rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, 1995.
21. L. Bush, J. Calman, C.L. Cherney, et al. (1989) High-level penicillin resistance among isolates of enterococci: Implications for treatment of enterococcal infections. Ann. Intern. Med. 110 515-520.
22. K.M. Butler (2006) Enterococcal infection in children. Semin. Pediatr. Infect. Dis. 17 128-139.
23. S.A. Calderwood, C. Wennersten and R.C. Moellering Jr. (1977) Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: Prevalence, evolution, and relationship to synergism with penicillin. Antimicrob. Agents Chemother. 12 401-405.
24. K. Carniol and M.S. Gilmore (2004) Signal transduction, quorum-sensing, and extracellular protease activity in Enterococcus faecalis biofilm formation. J. Bacteriol. 186 8161-8163.
25. F. Caron, M. Pestel, M.D. Kitzis, et al. (1995) Comparison of different β-lactam–glycopeptide-gentamicin combinations for and experimental endocarditis caused by highly β-lactam–resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. J. Infect. Dis. 171 106-112.
26. C.F. Carpenter and H.F. Chambers (2004) Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin. Infect. Dis. 38 994-1000.
27. Centers for Disease Control and Prevention (CDC) (2002) Staphylococcus aureus resistant to vancomycin—United States, 2002. M. M. W. R. Morbid. Mortal. Weekly Rep. 51(26), 565-567.
28. Centers for Disease Control and Prevention (CDC) (2004) Brief report: Vancomycin-resistant Staphylococcus aureus—New York, 2004. M. M. W. R. Morbid. Mortal. Weekly Rep. 53(15), 322-333.
29. E. Cercenado, G.M. Eliopoulos, C.B. Wennersten, et al. (1992) Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 36 2201-2203.
30. Y. Cetinkaya, P. Falk and C.G. Mayhall (2000) Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13 686-707.
31. C.E. Chenoweth, K.A. Robinson and D.R. Schaberg (1990) Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob. Agents Chemother. 34 1800-1802.
32. J.W. Chien, M.L. Kucia and R.A. Salata (2000) Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin. Infect. Dis. 30 146-151.
33. V.A. Chirurgi, S.E. Oster, A.A. Goldberg, et al. (1991) Ampicillin-resistant Enterococcus raffinosus in an acute-care hospital: Case-control study and antimicrobial susceptibilities. J. Clin. Microbiol. 29 2663-2665.
34. J.W. Chow (2000) Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 31 586-589.
35. J.W. Chow, A. Davidson, E. Sanford 3rd., et al. (1997) Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy. Clin. Infect. Dis. 24 91-92.
36. J.W. Chow, L.A. Thal, M.B. Perri, et al. (1993) Plasmid-associated hemolysin and aggregation substance production contributes to virulence in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 37 2474-2477.
37. J.W. Chow, M.J. Zervos, S.A. Lerner, et al. (1997) A novel gentamicin resistance gene in Enterococcus. Antimicrob. Agents Chemother. 41 511-514.
38. J.C. Christenson, E.K. Korgenski, E. Jenkins, et al. (1998) Detection of vancomycin-resistant enterococci colonization in a children's hospital. Am. J. Infect. Control 26 569-571.
39. C. Christie, J. Hammond, S. Reising, et al. (1994) Clinical and molecular epidemiology of enterococcal bacteremia in a pediatric teaching hospital. J. Pediatr. 125 392-399.
40. N.C. Clark, R.C. Cooksey, B.C. Hill, et al. (1993) Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37 2311-2317.
41. D. Clemett and A. Markham (2000) Linezolid. Drugs 59 815-827.
42. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement. CLSI document M100-S16, No. 3, Vol. 26. Wayne, PA, CLSI, 2006, pp. 96, 124-127.
43. P.S. Coburn, C.M. Pillar, B.D. Jett, et al. (2004) Enterococcus faecalis senses target cells and in response expresses cytolysin. Science 306 2270-2272.
44. M. Cohen (1992) Epidemiology of drug resistance: Implications for a post-antibiotic era. Science 257 1050-1055.
45. L.A. Collins, G.J. Malanoski, G.M. Eliopoulos, et al. (1993) In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob. Agents Chemother. 37 598-601.
46. P.E. Coudron, S.M. Markowitz and E.S. Wong (1992) Isolation of a beta-lactamase–producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob. Agents Chemother. 36 1125-1126.
47. P.E. Coudron, C.G. Mayhall and R.R. Facklam (1984) Streptococcus faecium outbreak in a neonatal intensive care unit. J. Clin. Microbiol. 20 1044.
48. C.R. Cox, P.S. Coburn and M.S. Gilmore (2005) Enterococcal cytolysin: A novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr. Protein Pept. Sci. 6 77-84.
49. A.S. Dajani (1993) Infective endocarditis. S.L. Kaplan (Eds) Current Therapy in Pediatric Infectious Diseases 3rd ed. St. Louis: Mosby–Year Book 129-133.
50. J.A. Daly, N.L. Clifton and K.C. Seskin (1991) Use of rapid, nonradioactive DNA probes in culture confirmation tests to detect Streptococcus agalactiae Haemophilus influenzae, and Enterococcus spp. from pediatric patients with significant infections. J. Clin. Microbiol. 29 80.
51. I. Das and J. Gray (1998) Enterococcal bacteremia in children: A review of seventy-five episodes in a pediatric hospital. Pediatr. Infect. Dis. J. 17 1154-1158.
52. H. Davies, E. Jones, R. Sheng, et al. (1992) Nosocomial urinary tract infections at a pediatric hospital. Pediatr. Infect. Dis. J. 11 349-354.
53. C.A. DiazGranados and J.A. Jernigan (2005) Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J. Infect. Dis. 191 588-595.
54. C.A. DiazGranados, S.M. Zimmer, M. Klein and J.A. Jernigan (2005) Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis. Clin. Infect. Dis. 41 327-333.
55. L.M. Deshpande, T.R. Fritsche, G.J. Moet, et al. (2007) Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 58 163-170.
56. S.R.M. Dobson and C.J. Baker (1990) Enterococcal sepsis in neonates: Features by age of onset and occurrence of focal infection. Pediatrics 85 165.
57. S. Donabedian, J.W. Chow, D.M. Shales, et al. (1995) DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J. Clin. Microbiol. 33 141-145.
58. C.J. Donskey, T.K. Chowdhry, M.T. Hecker, et al. (2000) Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343 1925-1932.
59. C.J. Donskey, J.A. Hanrahan, R.A. Hutton, et al. (2000) Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect. Dis. 181 1830-1833.
60. S. Dutka-Malen, S. Evers and P. Courvalin (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33 24-27.
61. M.B. Edmond, J.F. Ober, D.L. Weinbaum, et al. (1995) Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection. Clin. Infect. Dis. 20 1126-1133.
62. M.B. Edmond, S.E. Wallace, D.K. McClish, et al. (1999) Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin. Infect. Dis. 29 239-244.
63. G.M. Eliopoulos, C. Thauvin-Eliopoulos and R.C. Moellering Jr. (1992) Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin. Clin. Infect. Dis. 15 58-62.
64. G.M. Eliopoulos, C.B. Wennersten, H.S. Gold, et al. (1996) In vitro activities in new oxazolidinone antimicrobial agents against enterococci. Antimicrob. Agents Chemother. 40 1745-1747.
65. G.M. Eliopoulos, C.B. Wennersten, H.S. Gold, et al. (1998) Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob. Agents Chemother. 42 1088-1092.
66. R.R. Facklam and M.D. Collins (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27 731-734.
67. R. Facklam, N. Pigott, R. Franklin, et al. (1995) Evaluation of three disk tests for identification of enterococci, leuconostocs, and pediococci. J. Clin. Microbiol. 33 885-887.
68. R.R. Facklam, D.R. Sahm (1995) Enterococcus. P.R. Murray, E.J. Baron, M.A. Pfaller, et al., (Eds) Manual of Clinical Microbiology 6th ed. Washington, D.C.: American Society for Microbiology 308-314.
69. E.L. Fasola, J.A. Moody, C.J. Shanholtzer, et al. (1994) Bactericidal action of gentamicin against enterococci that are sensitive, or exhibit low- or high-level resistance to gentamicin. Diagn. Microbiol. Infect. Dis. 19 57-60.
70. D. Felmingham, A.P. Wilson, A.L. Quintant, et al. (1992) Enterococcus species in urinary tract infection. Clin. Infect. Dis. 15 295-301.
71. R. Fontana, G. Amalfitano, L. Rossi, et al. (1992) Mechanisms of resistance to growth inhibition and killing by β-lactam antibiotics in enterococci. Clin. Infect. Dis. 15 486-489.
72. H.S. Fraimow, D.L. Jungkind, D.W. Lander, et al. (1994) Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann. Intern. Med. 121 22-26.
73. French, G.: Safety and tolerability of linezolid. J. Antimicrob. Chemother. 51(Suppl. S2): ii45–ii53.
74. P.C. Fuchs, A.L. Barry and S.D. Brown (2002) In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 49 467-470.
75. W.B. Furlong and T.A. Rakowski (1997) Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. Clin. Infect. Dis. 25 163-164.
76. F. Garcia-Garrote, E. Cercenado and E. Bouza (2000) Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J. Clin. Microbiol. 38 2108-2111.
77. I.J. Gladstone, R.A. Ehrenkranz, S.C. Edberg, et al. (1990) A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr. Infect. Dis. J. 9 819-825.
78. H. Gold (2001) Vancomycin-resistant enterococci: Mechanisms and clinical observations. Clin. Infect. Dis. 33 210-219.
79. R.D. Gonzales, P.C. Schreckenberger, M.B. Graham, et al. (2001) Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357 1179.
80. G.L. Goodhard (1984) In vivo vs. in vitro susceptibility of Enterococcus to trimethoprim-sulfamethoxazole. J. A. M. A. 252 2748-2749.
81. S.L. Gorbach (1993) Intraabdominal infections. Clin. Infect. Dis. 17 961-967.
82. S. Gordon, J.M. Swenson, B.C. Hill, et al. (1992) Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States: Enterococcal Study Group. J. Clin. Microbiol. 30 2373-2378.
83. W. Graninger and R. Ragette (1992) Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin. Infect. Dis. 15 49-57.
84. J.W. Gray, P.J. Darbyshire, S.V. Beath, et al. (2000) Experience with quinupristin/dalfopristin in treating infections with vancomycin-resistant Enterococcus faecium in children. Pediatr. Infect. Dis. J. 19 234-238.
85. J.W. Gray and R.H. George (2000) Experience of vancomycin-resistant enterococci in a children's hospital. J. Hosp. Infect. 45 11-18.
86. J.W. Gray, S. Pedler, J. Kernahan, et al. (1992) Enterococcal superinfection in paediatric oncology patients treated with imipenem. Lancet 13 1487-1488.
87. M.L. Grayson, G.M. Eliopoulos, C.B. Wennersten, et al. (1991) Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: A 22-year review at one institution. Antimicrob. Agents Chemother. 35 2180-2184.
88. M.L. Grayson, C. Thauvin-Eliopoulos, G.M. Eliopoulos, et al. (1990) Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 34 1792-1794.
89. M. Green, J.H. Shlaes, K. Barbadora, et al. (1995) Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin. Infect. Dis. 20 712-714.
90. R.M. Gullberg, S.R. Homann and J.P. Phair (1989) Enterococcal bacteremia: Analysis of 75 episodes. Rev. Infect. Dis. 11 74-85.
91. S. Handwerger, B. Raucher, D. Altarac, et al. (1993) Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin. Infect. Dis. 16 750-755.
92. M.K. Hayden, G.M. Trenholme, J.E. Schultz, et al. (1993) In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J. Infect. Dis. 167 1224-1227.
93. K.J. Henning, H. Delencastre, J. Eagan, et al. (1996) Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: Duration of stool shedding and incidence of clinical infection. Pediatr. Infect. Dis. J. 15 848-854.
94. B.C. Herold, L.C. Immergluck, M.C. Maranan, et al. (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no predisposing factors. J. A. M. A. 279 593-598.
95. I.A. Herrero, N.C. Issa and R. Patel (2002) Nosocomial spread of linezolid-resistant vancomycin-resistant Enterococcus faecium. N. Engl. J. Med. 346 867-869.
96. E. Hershberger, S. Donabedian, K. Konstantinou and M.J. Zervos (2004) Quinupristin-dalfopristin resistance in gram-positive bacteria: Mechanism of resistance and epidemiology. Clin. Infect. Dis. 38 92-98.
97. C.W. Hoge, J. Adams, B. Buchanan, et al. (1991) Enterococcal bacteremia: To treat or not to treat, a reappraisal. Rev. Infect. Dis. 13 600-605.
98. E.W.I. Hook, R.B. Roberts and M.A. Sande (1975) Antimicrobial therapy of experimental endocarditis. Antimicrob. Agents Chemother. 8 564-570.
99. T. Horodniceanu, T. Bougueleret, N. El-Solh, et al. (1979) High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob. Agents Chemother 16 686-689.
100. C. Hunt, M. Dionne, M. Delorme, et al. (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. M. M. W. R. Morb. Mortal. Wkly. Rep. 48 707-710.
101. T.H. Hunter (1947) Use of streptomycin in treatment of bacterial endocarditis. Am. J. Med. 2 436-442.
102. M. Javaheri, R.N. Khurana, T.M. O'Hearn, et al. (2007) Linezolid-induced optic neuropathy: A mitochondrial disorder? Br. J. Ophthalmol. 91 111-115.
103. W.R. Jarvis and W.J. Martone (1992) Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 29(Suppl. A), 19-24.
104. B.D. Jett, M.M. Huycke and M.S. Gilmore (1994) Virulence of enterococci. Clin. Microbiol. Rev. 7 462-478.
105. A.P. Johnson (1994) The pathogenicity of enterococci. J. Antimicrob. Chemother. 33 1083-1089.
106. D.H. Johnson, A. Rosenthal and A.S. Nadas (1975) Bacterial endocarditis in children under 2 years of age. Am. J. Dis. Child. 129 183-186.
107. D.H. Johnson, A. Rosenthal and A.S. Nadas (1975) A forty-year review of bacterial endocarditis in infants and children. Circulation 51 581-588.
108. M.E. Jones, D.C. Draghi, C. Thornsberry, et al. (2004) Emerging resistance among bacterial pathogens in the intensive care unit—a European and North American Surveillance study (2000-2002). Ann. Clin. Microbiol. Antimicrob. 3 1-11.
109. R.N. Jones, M.E. Erwin and S.C. Anderson (1995) Emerging multiply resistant enterococci among clinical isolates. II. Validation of the e-test to recognize glycopeptide-resistant strains. Diagn. Microbiol. Infect. Dis. 21 95-100.
110. R.N. Jones, H.S. Sader, M.E. Erwin and S.C. Anderson (1995) Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States: Enterococcus Study Group. Diagn. Microbiol. Infect. Dis. 21 85-93.
111. Jones, R.N., Turnidge, J., Sader, H.S., et al.: Evolutionary trends in antimicrobial resistance in E. faecium bacteremia: Report from the SENTRY Antimicrobial Surveillance Program (1997-2005). Abstract C2-208. Presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 27-30, 2006.
112. G.W. Kaatz and S.M. Seo (1996) In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40 799-801.
113. A.H. Kaplan, P.H. Gilligan and R.R. Facklam (1988) Recovery of resistant enterococci during vancomycin prophylaxis. J. Clin. Microbiol. 26 1216-1218.
114. S.L. Kaplan, J.G. Deville, R. Yogev, et al., for the Linezolid Pediatric Study Group (2003) Linezolid versus vancomycin for treatment of resistant gram-positive infections in children. Pediatr. Infect. Dis. J. 22 677-685.
115. S.L. Kaplan, K.G. Hulten, B.E. Gonzalez, et al. (2005) Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40 1785-1791.
116. D. Kapur, D. Dorsky, J.M. Feingold, et al. (2000) Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 25 147-152.
117. L.V. Karanfil, M. Murphy and A. Josephson (1993) A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect. Control Hosp. Epidemiol. 13 195-200.
118. A. Kaufhold and P. Ferrieri (1993) The microbiologic aspects, including diagnosis, of beta-hemolytic streptococcal and enterococcal infections. Infect. Dis. Clin. North Am. 7 235-256.
119. B.D. Kirkpatrick, S.M. Harrington, D. Smith, et al. (1999) An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin. Infect. Dis. 29 1268-1273.
120. H.A. Kirst, D.G. Thompson and T.I. Nicas (1998) Historical yearly usage of vancomycin. Antimicrob. Agents Chemother. 42 1303-1304.
121. J.O. Klein and S.M. Marcy (1995) Bacterial sepsis and meningitis. J.S. Remington, J.O. Klein (Eds) Infectious Diseases of the Fetus and Newborn Infant 4th ed. Philadelphia: W. B. Saunders 835-890.
122. C.T. Koorevaar, P.G. Scherpenzeel, H.J. Neijens, et al. (1992) Childhood meningitis caused by enterococci and viridans streptococci. Infection 20 118-121.
123. B. Kreft, R. Marre, U. Schramm, et al. (1992) Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect. Immun. 60 25-30.
124. J.N. Krieger, D.L. Kaiser and R.P. Wenzel (1983) Urinary tract etiology of bloodstream infections in hospitalized patients. J. Infect. Dis. 146 719-723.
125. C. Kunin (1993) Resistance to antimicrobial drugs: A worldwide calamity. Ann. Intern. Med. 118 557-561.
126. N. Kvirikadze, N. Suseno, T. Vescio, et al. (2006) Daptomycin for the treatment of vancomycin-resistant Enterococcus faecium bacteremia. Scand. J. Infect. Dis. 38 290-292.
127. E.J. Law, K. Blecher and J.M. Still (1994) Enterococcal infections as a cause of mortality and morbidity in patients with burns. J. Burn. Care Rehabil. 15 236-239.
128. R. LeClercq, E. Derlot, J. Duval, et al. (1988) Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319 157-161.
129. R. LeClercq, S. Dutka-Malen, A. Brisson-Noel, et al. (1992) Resistance of enterococci to aminoglycosides and glycopeptides. Clin. Infect. Dis. 15 495-501.
130. R. LeClercq, S. Dutka-Malen, A. Brisson-Noel, et al. (1993) Resistance of enterococci to aminoglycosides and glycopeptides. Letter. Clin. Infect. Dis. 16 331.
131. P.K. Linden, A.W. Pasculle, D. McDevitt, et al. (1997) Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: Comparison with a control cohort. J. Antimicrob. Chemother. 39 145-151.
132. L.L. Livornese Jr., S. Dias, C. Samel, et al. (1992) Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann. Intern. Med. 117 112-116.
133. A.M. Loeffler, R.H. Drew, J.R. Perfect, et al. (2002) Safety and efficacy of quinupristin/dalfopristin for treatment of invasive gram-positive infections in pediatric patients. Pediatr. Infect. Dis. J. 21 950-956.
134. J.A. Lohr, L.G. Donowitz and J.E. Sadler III (1989) Hospital-acquired urinary tract infection. Pediatrics 83 193-199.
135. J.K. Long, T.K. Choueiri, G.S. Hall, et al. (2005) Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clin. Proc. 80 1215-1216.
136. G. Losonsky, A. Wolf, R. Schwalbe, et al. (1994) Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin. Infect. Dis. 19 163-165.
137. D.E. Low (1995) Quinupristin/dalfopristin: Spectrum of activity, pharmacokinetics, and initial clinical experience. Microb. Drug Resist. 1 223-234.
138. D.E. Low, N. Keller, A. Barth, et al. (2001) Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl.), 133-145.
139. D.E. Low, B.M. Willey and A.J. McGeer (1995) Multidrug-resistant enterococci: A threat to the surgical patient. Am. J. Surg. 169(Suppl.), 8-12.
140. L.M. Luginbuhl, H.A. Rotbart, R.R. Facklam, et al. (1987) Neonatal enterococcal sepsis: Case-control study and description of an outbreak. Pediatr. Infect. Dis. J. 6 1022-1030.
141. W.A. Lynn, E. Clutterbuck, S. Want, et al. (1994) Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 344 1025-1026.
142. D.G. Maki and W.A. Agger (1988) Enterococcal bacteremia: Clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 67 248-269.
143. D.A. Malone, R.A. Wagner, J.P. Myers, et al. (1986) Enterococcal bacteremia in two large community teaching hospitals. Am. J. Med. 81 601-606.
144. S.H. Marshall, C.J. Donskey, R. Hutton-Thomas, et al. (2002) Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 46 3334-3336.
145. S. Matsumura and A.E. Simor (1998) Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: A synergistic drug combination. Clin. Infect. Dis. 27 1554-1556.
146. A. McCarthy, G. Victor, K. Ramotar, et al. (1994) Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J. Clin. Microbiol. 32 2671-2676.
147. D.F. McNeeley, F. Saint-Louis and G.J. Noel (1996) Neonatal enterococcal bacteremia: An increasingly frequent event with potentially untreatable pathogens. Pediatr. Infect. Dis. J. 15 800-805.
148. S.A. McNeil, N.M. Clark, P.H. Chandrasekar, et al. (2000) Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with Synercid (quinupristin/dalfopristin). Clin. Infect. Dis. 30 403-404.
149. B.D. Mederski-Samoraj and B.E. Murray (1983) High-level resistance to gentamicin in clinical isolates of enterococci. J. Infect. Dis. 147 751-757.
150. D.W. Megran (1992) Enterococcal endocarditis. Clin. Infect. Dis. 15 63-71.
151. V.G. Meka and H.S. Gold (2004) Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39 1010-1015.
152. R.C. Moellering Jr. (1992) Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14 1173-1176.
153. R.C. Moellering Jr. (2005) Enterococcus species, Streptococcus bovis, and Leuconostoc species. G.L. Mandell, J.E. Bennett, R. Dolin (Eds) Principles and Practice of Infectious Diseases 6th ed. Philadelphia: Elsevier Churchill Livingstone
154. R.C. Moellering Jr. and D.J. Krogstad (1979) Antibiotic resistance in enterococci. D. Schlessinger (Eds) Microbiology—1979 Washington, D.C.: American Society for Microbiology 293-298.
155. R.C. Moellering Jr., P.K. Linden, J. Reinhardt, et al. (1999) The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium: Synercid Emergency-Use Study Group. J. Antimicrob. Chemother. 44 251-261.
156. R.C. Moellering Jr. and A.N. Weinberg (1971) Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake of C14-labeled streptomycin by enterococci. J. Clin. Invest. 50 2580-2584.
157. R.C. Moellering Jr., C. Wennersten and T. Medrek (1970) Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob. Agents Chemother. 1 335-340.
158. K.E. Mondy, W. Shannon and L.M. Mundy (2001) Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin. Infect. Dis. 33 473-476.
159. M.A. Montecalvo, H. Horowitz and C. Gedris (1994) Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob. Agents Chemother. 38 1363-1367.
160. F. Moreno, P. Grota, C. Crisp, et al. (1995) Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin. Infect. Dis. 21 1234-1237.
161. J.G. Morris Jr., D.K. Shay, J.N. Hebden, et al. (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann. Intern. Med. 123 250-259.
162. A.J. Morrison Jr. and R.P. Wenzel (1986) Nosocomial urinary tract infections due to enterococcus: Ten years' experience at a university hospital. Arch. Intern. Med. 146 1549-1551.
163. L.S. Munoz-Price, K. Lolans and J.P. Quinn (2005) Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin. Infect. Dis. 41 565-566.
164. B.E. Murray (1990) The life and times of the enterococcus. Clin. Microbiol. Rev. 3 46-65.
165. B.E. Murray (1992) Beta-lactamase–producing enterococci. Antimicrob. Agents Chemother. 36 2355-2359.
166. B.E. Murray (1995) Editorial response: What can we do about vancomycin-resistant enterococci. Clin. Infect. Dis. 20 1134-1136.
167. B.E. Murray (1998) Diversity among multidrug-resistant enterococci. Emerg. Infect. Dis. 4 37-47.
168. B.E. Murray (2000) Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342 710-721.
169. B.E. Murray and B. Mederski-Samoraj (1983) Transferable beta-lactamase: A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J. Clin. Invest. 72 1168.
170. S.A. Nachman, R. Verma and M. Egnor (1995) Vancomycin-resistant Enterococcus faecium shunt infection in an infant: An antibiotic cure. Microb. Drug Resist. 1 95-96.
171. K. Nagai, K. Yuge, E. Ono, et al. (1994) Enterococcus faecium meningitis in a child. Pediatr. Infect. Dis. J. 13 1016-1017.
172. W.F. Nauschuetz, S.B. Trevino, L.S. Harrison, et al. (1993) Enterococcus casseliflavus as an agent of nosocomial bloodstream infections. Med. Microbiol. Lett. 2 102-108.
173. R.L. Nichols and A.C. Muzik (1992) Enterococcal infections in surgical patients: The mystery continues. Clin. Infect. Dis. 15 72-76.
174. G. Nicoletti and S. Stefain (1995) Enterococci: Susceptibility patterns and therapeutic options. Eur. J. Clin. Microbiol. Infect. Dis. 14(Suppl.), 33-37.
175. C.J. Noble (1978) Carriage of group D streptococci in the human bowel. J. Clin. Pathol. 31 1182-1186.
176. W.C. Noble, Z. Virani and R. Cree (1992) Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus. F. E. M. S. Microbiol. Lett. 93 195-198.
177. A.H. Norris, J.P. Reilly, P.H. Edelstein, et al. (1995) Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin. Infect. Dis. 20 1137-1144.
178. G.A. Noskin, F. Siddiqui, V. Stosor, et al. (1999) Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin. Clin. Infect. Dis. 28 689-690.
179. G.A. Noskin, F. Siddiqui, V. Stosor, et al. (1999) In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 43 2059-2062.
180. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. M. M. W. R. Morb. Mortal. Wkly. Rep. 42(30), 597-599.
181. A.B. Onderdonk, J.G. Bartlett, T.J. Louie, et al. (1976) Microbial synergy in experimental intra-abdominal abscess. Infect. Immun. 12 22-26.
182. B.E. Ostrowsky, W.E. Trick, A.H. Sohn, et al. (2001) Control of vancomycin-resistant enterococcus in health care facilities in a region. N. Engl. J. Med. 344 1427-1433.
183. R. Patel, S.L. Allen, J.M. Manahan, et al. (2001) Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl. Surg. 7 27-31.
184. R. Patel, M.R. Keating, F.R. Cockerill, et al. (1993) Bacteremia due to Enterococcus avium. Clin. Infect. Dis. 17 1006-1011.
185. J.E. Patterson, A.H. Sweeney, M. Simms, et al. (1995) An analysis of 110 serious enterococcal infections, epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74 191-200.
186. J.E. Patterson and M.J. Zervos (1990) High-level gentamicin resistance in enterococcus: Microbiology, genetic basis, and epidemiology. Rev. Infect. Dis. 12 644.
187. W.N. Patton, N. Bienz, I.M. Franklin, et al. (1991) Enterococcal meningitis in an HIV positive hemophilic patient. J. Clin. Pathol. 44 608-609.
188. S. Perez Mato, S. Robinson and R.E. Begue (1999) Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr. Infect. Dis. J. 18 483-484.
189. D.D. Poutsiaka, S. Skiffington, K.B. Miller, et al. (2007) Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J. Infect. 54 567-571.
190. E. Presterl, W. Graninger and A. Georgopoulos (1993) The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria. J. Antimicrob. Chemother. 31 755-766.
191. N.J. Pultz, U. Stiefel, S. Subramanyan, et al. (2005) Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J. Infect. Dis. 191 949-956.
192. N.J. Raymond, J. Henry and K.A. Workowski (1995) Enterococcal arthritis: Case report and review. Clin. Infect. Dis. 21 516-522.
193. Recommendations for preventing the spread of vancomycin resistance (1995) Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). M. M. W. R. Recomm. Rep. 44(RR-12), 1-13.
194. E. Rhinehart, N.E. Smith, C. Wennersten, et al. (1990) Rapid dissemination of beta-lactamase–producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N. Engl. J. Med. 323 1814-1818.
195. J.C. Ricaurte, H.W. Boucher, G.S. Turett, et al. (2001) Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. Clin. Microbiol. Infect. 7 17-21.
196. L.B. Rice (2001) Emergence of vancomycin-resistant enterococci. Emerg. Infect. Dis. 7 183-187.
197. L.B. Rice, S.B. Calderwood, G.M. Eliopoulos, et al. (1991) Enterococcal endocarditis: A comparison of prosthetic and native valve disease. Rev. Infect. Dis. 13 1-7.
198. L.B. Rice, L.L. Carias, R. Hutton-Thomas, et al. (2001) Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 45 1480-1486.
199. L.B. Rice and D.M. Shlaes (1995) Vancomycin resistance in the enterococcus. Pediatr. Clin. North Am. 42 601-618.
200. M.J. Richards, J.R. Edwards, D.H. Culver, et al., for the National Nosocomial Infections Surveillance System (1999) Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 103 e39.
201. M. Ries, K.H. Deeg, U. Heininger, et al. (1993) Brain abscesses in neonates—report of three cases. Eur. J. Pediatr. 152 745-746.
202. L.G. Rubin, V. Tucci, E. Cercenado, et al. (1992) Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect. Control Hosp. Epidemiol. 13 700-705.
203. J.C. Rucker, S.R. Hamilton, D. Bardenstein, et al. (2006) Linezolid-induced toxic optic neuropathy. Neurology 66 595-598.
204. K. Sabol, J.E. Patterson, J.S. Lewis II, et al. (2005) Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob. Agents Chemother. 49 1664-1665.
205. H.S. Sader, M.A. Pfaller, F.C. Tenover, et al. (1994) Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J. Clin. Microbiol. 31 2840-2842.
206. H.S. Sader, J.M. Streit, T.R. Fritsche and R.N. Jones (2004) Antimicrobial activity of daptomycin against multidrug-resistant gram-positive strains collected worldwide. Diagn. Microbiol. Infect. Dis. 50 201-204.
207. V.S. Sahgal, C. Urban, N. Mariano, et al. (1995) Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: Case report. Microb. Drug Resist. 1 245-247.
208. L. Saiman, J. Goldfarb, S.A. Kaplan, et al. (2003) Safety and tolerability of linezolid in children. Pediatr. Infect. Dis. J. 22 S193-S200.
209. M.L. Sanchez, M.S. Barrett and R.N. Jones (1992) The E-test applied to susceptibility tests of gonococci, multiply resistant enterococci, and Enterobacteriaceae producing potent beta-lactamases. Diagn. Microbiol. Infect. Dis. 15 459-462.
210. V. Sastry, P.J. Brennan, M.M. Levy, et al. (1995) Vancomycin-resistant enterococci: An emerging pathogen in immunosuppressed transplant recipients. Transplant. Proc. 27 954-955.
211. D.R. Schaberg, D.H. Culver and R.P. Gaynes (1991) Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B), 72-75.
212. D.R. Schaberg, W.I. Dillon, M.S. Terpenning, et al. (1992) Increasing resistance of enterococci to ciprofloxacin. Antimicrob. Agents Chemother. 36 2533-2535.
213. J. Schmit (1992) Efficacy of teicoplanin for enterococcal infections: 63 cases and review. Clin. Infect. Dis. 15 302-306.
214. S.C. Schoenbaum, P. Gardner and J. Shillito (1975) Infections of cerebrospinal fluid shunts: Epidemiology, clinical manifestations, and therapy. J. Infect. Dis. 131 543-552.
215. F. Schuster, U.B. Graubner, I. Schmid, et al. (1998) Vancomycin-resistant-enterococci—colonization of 24 patients on a pediatric oncology unit. Klin. Padiatr. 210 261-263.
216. Schwartz, M., Slavoski, L., and Dash, G., et al: Nosocomial outbreak of multi-resistant Enterococcus durans (VRED): Description of the epidemiology and antimicrobial sensitivity testing. Abstract 68. Presented at the 33rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, 1995.
217. J. Seedat, G. Zick, I. Klare, et al. (2006) Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Antimicrob. Agents Chemother. 50 4217-4219.
218. J.A. Segreti, C.W. Crank and M.S. Finney (2006) Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients. Pharmacotherapy 26 347-352.
219. Z.H. Shaikh, C.A. Peloquin and C.D. Ericsson (2001) Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: Case report and literature review. Scand. J. Infect. Dis. 33 375-379.
220. D.K. Shay, D.A. Goldman and W.R. Jarvis (1995) Reducing the spread of antimicrobial-resistant microorganisms: Control of vancomycin-resistant enterococci. Pediatr. Clin. North Am. 42 703-716.
221. D.K. Shay, S.A. Maloney, M. Montecalvo, et al. (1995) Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J. Infect. Dis. 172 993-1000.
222. J.M. Sherman (1937) The streptococci. Bacteriol. Rev. 1 3-97.
223. D.M. Shlaes, L. Etter and L. Gutmann (1991) Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin and gentamicin. Antimicrob. Agents Chemother. 35 776-779.
224. D.M. Shlaes, J. Levy and E. Wolinsky (1981) Enterococcal bacteremia without endocarditis. Arch. Intern. Med. 141 578-581.
225. T.E. Shuler, C.D. Riddle Jr. and D.W. Potts (1990) Polymicrobic septic arthritis caused by Kingella kingae and Enterococcus. Orthopedics 13 254-256.
226. J.S. Siegel and G.H. McCracken Jr. (1978) Group D streptococcal Infections. J. Pediatr. 93 542-543.
227. J.A. Silverman, L.I. Mortin, A.D. Vanpraagh, et al. (2005) Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact. J. Infect. Dis. 191 2149-2152.
228. W.A. Simpson, H.S. Courtney and I. Ofek (1987) Interactions of fibronectin with streptococci: The role of fibronectin as a receptor for Streptococcus pyogenes. Rev. Infect. Dis. 9(Suppl.), 351-359.
229. N. Singh-Naz, A. Sleemi, A. Pikis, et al. (1999) Vancomycin-resistant Enterococcus faecium colonization in children. J. Clin. Microbiol. 37 413-416.
230. B.F. Stanton, R.S. Baltimore and J.D. Clemens (1984) Changing spectrum of infective endocarditis in children. Am. J. Dis. Child 138 720-725.
231. J.R. Starke (2004) Infective endocarditis. R.D. Feigin, J.D. Cherry, G.J. Demmler, S.L. Kaplan (Eds) Textbook of Pediatric Infectious Diseases 5th ed. Philadelphia: W. B. Saunders 355-380.
232. J.N. Steenbergen, J. Alder, G.M. Thorne and F.P. Tally (2005) Daptomycin: A lipopeptide antibiotic for the treatment of serious gram-positive infections. J. Antimicrob. Chemother. 55 283-288.
233. M.P. Stevens and M.B. Edmond (2005) Endocarditis due to vancomycin-resistant enterococci: Case report and review of the literature. Clin. Infect. Dis. 41 1134-1142.
234. K.B. Stevenson, E.W. Murray and F.A. Sarubbi (1994) Enterococcal meningitis: Report of four cases and review. Clin. Infect. Dis. 18 233-239.
235. J.M. Swenson, N.C. Clark, M.J. Ferraro, et al. (1994) Development of a standardized screening method for detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 32 1700-1704.
236. J.M. Swenson, M.J. Ferraro, D.F. Sahm, et al. (1992) New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on enterococci. J. Clin. Microbiol. 30 2525-2528.
237. J.M. Swenson, J.A. Hindler, L.R. Peterson (1995) Special tests for detecting antibacterial resistance. P.R. Murray, E.J. Baron, M.A. Pfaller, et al., (Eds) Manual of Clinical Microbiology 6th ed. Washington, D.C.: American Society for Microbiology 1356-1367.
238. H. Takada, Y. Kawabata, R. Arakaki, et al. (1995) Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect. Immun. 63 57-65.
239. O.H. Teixeira and C.K. Francis (1982) Enterococcal endocarditis in early infancy. Can. Med. Assoc. J. 127 612-613.
240. P.M. Tendolkar, A.S. Baghdayan, M.S. Gilmore and N. Shankar (2004) Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect. Immun. 72 6032-6039.
241. F.C. Tenover, J.M. Swenson, C.M. O'Hara, et al. (1995) Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33 1524-1527.
242. F.C. Tenover, L.M. Weigel, P.C. Appelbaum, et al. (2004) Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48 275-280.
243. M.G. Threlkeld and C.G. Cobbs (1995) Infectious disorders of prosthetic valves and intravascular devices. G.L. Mandell, J.E. Bennett, R. Dolin (Eds) Principles and Practices of Infectious Diseases 4th ed. New York: Churchill Livingstone 783-793.
244. R.W. Tofte, J. Solliday and K.B. Crossley (1984) Susceptibilities of enterococci to twelve antibiotics. Antimicrob. Agents Chemother. 25 532-533.
245. G.M. Tush, S. Huneycutt, A. Phillips, et al. (1998) Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection. Clin. Infect. Dis. 26 1460-1461.
246. Urdaneta, M., Hollis, F.Sperber, S.J.: Vancomycin resistant enterococci in the blood: Do we need to treat? Abstract 65. Presented at the 33rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, 1995.
247. A.H. Uttley, C.H. Collins, J. Naidoo, et al. (1988) Vancomycin-resistant enterococci. Letter. Lancet 1 57-58.
248. N. van Den Braak, W. Goessens, A. van Belkum, et al. (2001) Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. J. Clin. Microbiol. 39 351-353.
249. A. Verma, A. Dhawan, J. Philpott-Howard, et al. (2001) Glycopeptide- resistant Enterococcus faecium infections in paediatric liver transplant recipients: Safety and clinical efficacy of quinupristin/dalfopristin. J. Antimicrob. Chemother. 47 105-108.
250. M. Verma, J. Chatwal and P. Varughese (1994) Neonatal conjunctivitis: A profile. Indian Pediatr 31 1357-1361.
251. H. von Baum, J. Schehl, H.K. Geiss, et al. (1999) Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure: Mid-European Pediatric Peritoneal Dialysis Study Group. Clin. Infect. Dis. 29 912-916.
252. L.M. Weigel, R.M. Donlan, D.H. Shin, et al. (2007) High-level vancomycin-resistant Staphylococcus aureus (VRSA) associated with a polymicrobial biofilm. Antimicrob. Agents Chemother. 51 231-238.
253. J.A. Weigelt, S.M. Easley, E.R. Thal, et al. (1993) Abdominal surgical wound infection is lowered with improved perioperative Enterococcus and Bacteroides therapy. J. Trauma 34 579-584.
254. B.M. Willey, B.N. Kreiswirth, A.E. Simor, et al. (1992) Detection of vancomycin resistance in enterococcus species. J. Clin. Microbiol. 30 1621-1624.
255. B.M. Willey, A.J. McGeer, M.A. Ostrowski, et al. (1994) The use of the molecular typing techniques in the epidemiologic investigation of resistant enterococci. Infect. Control Hosp. Epidemiol. 15 548-556.
256. R. Williamson, C. LeBouguenec, L. Gutmann, et al. (1985) One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J. Gen. Microbiol. 131 1933-1940.
257. W.R. Wilson, A.W. Karchmer, A.S. Dajani, et al. (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association. J. A. M. A. 274 1706-1713.
258. W.R. Wilson, C.J. Wilkowske, A.J. Wright, et al. (1984) Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann. Intern. Med. 100 816-823.
259. J. Winberg, H.J. Anderson and T. Bergstrom (1974) Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr. Scand. Suppl. 252 1.
260. D.J. Winston, C. Emmanouilides, A. Kroeber, et al. (2000) Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clin. Infect. Dis. 30 790-797.
261. H. Wisplinghoff, T. Bischoff, S.M. Tallent, et al. (2004) Nosocomial bloodstream infections in U.S. hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39 309-317.
262. H. Wisplinghoff, H. Seifert, S.M. Tallent, et al. (2003) Nosocomial bloodstream infections in pediatric patients in United States hospitals: Epidemiology, clinical features and susceptibilities. Pediatr. Infect. Dis. J. 22 686-691.
263. T. Zakrzewski and J.D. Keith (1965) Bacterial endocarditis in infants and children. J. Pediatr. 67 1179-1193.
264. C. Zeana, C.J. Kubin, P. Della-Latta, et al. (2001) Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of the literature. Clin. Infect. Dis. 33 477-482.
265. M.J. Zervos and D.S. Schaberg (1985) Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob. Agents Chemother. 28 446-448.
266. R.A. Zimmerman, R.C. Moellering Jr. and A.N. Weinberg (1971) Mechanism of resistance to antibiotic synergism in enterococci. J. Bacteriol. 105 873-879.
267. K.K. Zscheck and B.E. Murray (1993) Genes involved in the regulation of beta-lactamase production in enterococci and staphylococci. Antimicrob. Agents Chemother. 37 1966-1970.
268. G.E. Zurenko, B.H. Yagi, R.D. Schaadt, et al. (1996) In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40 839-845.
269. J.T. Adams and R.G. Faix (1994) Streptococcus mitis infection in newborns. J. Perinatol. 14 473-478.
270. O. Adeotoye and R. Kupfer (1999) Streptococcus viridans vertebral osteomyelitis. J. R. Soc. Med. 92 306-307.
271. S. Alaluusua (1991) Transmission of mutans streptococci. Proc. Finn. Dent. Soc. 87 443-447.
272. S. Alam, S.R. Brailsford, R.A. Whiley, et al. (1999) PCR-based methods for genotyping viridans group streptococci. J. Clin. Microbiol. 37 2772-2776.
273. B. Albini, R.J. Nisengard, I. Glurich, et al. (1985) Streptococcus mutans–induced nephritis in rabbits. Am. J. Pathol. 118 408-418.
274. F. Alcaide, J. Carratala, J. Linares, et al. (1996) In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob. Agents Chemother. 40 2117-2120.
275. M. Alvarez, M.E. Alvarez, L. Maiz, et al. (1998) Antimicrobial susceptibility profiles of oropharyngeal viridans group streptococci isolates from cystic fibrosis and non-cystic fibrosis patients. Microb. Drug Resist. 4 123-128.
276. M.H. Anderson, M.P. Molvar and L.V. Powell (1991) Treating dental caries as an infectious disease. Oper. Dent. 16 21-28.
277. I. Ariel and D.B. Singer (1991) Streptococcus viridans infections in midgestation. Pediatr. Pathol. 11 75-83.
278. M. Arning, A. Gehrt, C. Aul, et al. (1990) Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemia. Blut 61 364-368.
279. R.R. Arnold, J. Mestecky and J.R. McGhee (1976) Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect. Immun. 14 355-362.
280. S. Asikainen and S. Alaluusua (1993) Bacteriology of dental infections. Eur. Heart. J. 14(Suppl. K), 43-50.
281. A. Awada, P. van der Auwera, F. Meunier, et al. (1992) Streptococcal and enterococcal bacteremia in patients with cancer. Clin. Infect. Dis. 15 33-48.
282. C. Barbadillo, A. Trujillo, E. Cuende, et al. (1990) Septic arthritis due to Streptococcus viridans. Clin. Exp. Rheumatol. 8 520-521.
283. G.J. Barker, S.K. Call and A.S. Gamis (1995) Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis. J. Pediatr. Hematol. Oncol. 17 151-155.
284. N.T. Bateman, S.J. Eykyn and I. Phillips (1975) Pyogenic liver abscess caused by Streptococcus milleri. Lancet 1 657-659.
285. A. Beck (1979) Interference by an alpha-hemolytic Streptococcus of beta-hemolytic pathogenic streptococci. Inflammation 3 463-465.
286. S. Benabdelmoumene, S. Dumont, C. Petit, et al. (1991) Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: Immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect. Immun. 59 3261-3266.
287. G. Berlot, A. Tomasini, V. Cioffi, et al. (1997) Fatal Streptococcus viridans descending mediastinitis: Case report and review of the literature. Eur. J. Emerg. Med. 4 111-114.
288. J.P. Bernard, P. Francioli and M. Glauser (1981) Vancomycin prophylaxis of experimental Streptococcus sanguis: Inhibition of bacterial adherence rather than bacterial killing. J. Clin. Invest. 68 1113-1116.
289. R. Berner, S. Sauter, U. Duffner, et al. (1998) Bacteremic episodes in pediatric oncologic patients, especially caused by the Streptococcus viridans group. Klin. Padiatr. 210 256-260.
290. P. Berney and P. Francioli (1990) Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J. Infect. Dis. 161 281-285.
291. F. Bert, L. Noussair, N. Lambert-Zechovsky, et al. (2005) Viridans group streptococci: An underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Eur. J. Gastroenterol. Hepatol. 17 929-933.
292. B. Bertrand, P. Rombaux, P. Eloy, et al. (1997) Sinusitis of dental origin. Acta Otorhinolaryngol. Belg. 51 315-322.
293. G.E. Bignardi and D. Isaacs (1989) Neonatal meningitis due to Streptococcus mitis. Rev. Infect. Dis. 11 86-88.
294. S. Bilgrami, J.M. Feingold, D. Dorsky, et al. (1998) Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 21 591-595.
295. A.L. Bisno, W.E. Dismukes, D.T. Durack, et al. (1989) Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. J. A. M. A. 261 1471-1477.
296. P.Y. Bochud, T. Calandra and P. Francioli (1994) Bacteremia due to viridans streptococci in neutropenic patients: A review. Am. J. Med. 97 256-264.
297. P.Y. Bochud, P. Eggiman, T. Calandra, et al. (1994) Bacteremia due to viridans Streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors. Clin. Infect. Dis. 18 25-31.
298. D.A. Boenning, L.P. Nelson and J.M. Campos (1988) Relatively penicillin-resistant Streptococcus sanguis endocarditis in an adolescent. Pediatr. Infect. Dis. J. 7 205-207.
299. A.P. Bos, W.P. Fetter, W. Baerts, et al. (1992) Streptococcal pharyngitis and epiglottitis in a newborn infant. Eur. J. Pediatr. 151 874-875.
300. D. Bratthall (1991) Mutans streptococci: Dental, oral and global aspects. J. Indian Soc. Pedod. Prev. Dent. 9 4-12.
301. K. Bromberg, J.M. Orson, R. Triedman, et al. (1980) Erythromycin-resistant Streptococcus viridans in oral flora with prolonged erythromycin therapy. Ann. Intern. Med. 93 931-932.
302. R.A. Broughton, R. Krafka and C.J. Baker (1981) Non–group D alpha-hemolytic streptococci: New neonatal pathogens. J. Pediatr. 99 450-454.
303. L. Bruckner and F. Gigliotti (2006) Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin. Pediatr. Infect. Dis. 17 153-160.
304. L.B. Bruckner, D.N. Korones, T. Karnauchow, et al. (2002) High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J. Pediatr. 140 20-26.
305. A.S. Brunet, C. Ploton, C. Galambrun, et al. (2006) Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia. Pediatr. Blood Cancer 47 765-772.
306. A.L. Buchman (1990) Streptococcus viridans osteomyelitis with endocarditis presenting as acute onset lower back pain. J. Emerg. Med. 8 291-294.
307. A.D. Burden, B.A. Oppenheim, D. Crowther, et al. (1991) Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur. J. Cancer 27 409-411.
308. A. Buxbaum and A. Georgopoulos (1996) Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae Pseudomonas aeruginosa and Streptococcus viridans. Infection 24 459-464.
309. J. Carlsson (1968) A numerical taxonomic study of human oral streptococci. Odontol. Rev. 19 137-160.
310. P.W. Caufield, G.R. Cutter and A.P. Dasanayake (1993) Initial acquisition of mutans streptococci by infants: Evidence for a discrete window of infectivity. J. Dent. Res. 72 37-45.
311. P.W. Caufield, A.P. Dasanayake, Y. Li, et al. (2000) Natural history of Streptococcus sanguinis in the oral cavity of infants: Evidence for a discrete window of infectivity. Infect. Immun. 68 4018-4023.
312. P.W. Caufield and Y.M. Wannemuehler (1982) In vitro susceptibility of S treptococcus mutans 6715 to iodine and sodium fluoride, singly and in combination, at various pH values. Antimicrob. Agents Chemother. 22 115-119.
313. L. Chalkley, C. Schuster, E. Potgieter, et al. (1991) Relatedness between Streptococcus pneumoniae and viridans streptococci: Transfer of penicillin resistance determinants and immunological similarities of penicillin-binding proteins. F. E. M. S. Microbiol. Lett. 69 35-42.
314. H.F. Chambers, Q. Xiang, Q. Liu, et al. (1999) Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrob. Agents Chemother. 43 2742-2746.
315. B. Chiu (1999) Multiple infections in carotid atherosclerotic plaques. Am. Heart J. 138(Suppl.), 534-536.
316. D.L. Church and H.E. Bryant (1989) Investigation of a Streptococcus viridans pseudobacteremia epidemic at a university teaching hospital. Infect. Control Hosp. Epidemiol. 10 416-421.
317. D.C. Classen, J.P. Burke, C.D. Ford, et al. (1990) Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am. J. Med. 89 441-446.
318. J. Cohen, J.P. Donnelly, A.M. Worsley, et al. (1983) Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 2 1452-1454.
319. G. Coleman and R.E.A. Williams (1972) Taxonomy of some human viridans streptococci. L.W. Wannamaker, J.M. Matsen (Eds) Streptococci and Streptococcal Diseases: Recognition, Understanding, and Management New York: Academic Press 282-299.
320. B.A. Collin, H.L. Leather, J.R. Wingard, et al. (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin. Infect. Dis. 33 947-953.
321. M.A. Corson, K.P. Postlethwaite and R.A. Seymour (2001) Are dental infections a cause of brain abscess?. Case report and review of the literature. Oral Dis 7 61-65.
322. W.A. Coulter, A. Coffey, I.D. Saunders, et al. (1990) Bacteremia in children following dental extraction. J. Dent. Res. 69 1691-1695.
323. A.L. Coykendall (1989) Classification and identification of the viridans streptococci. Clin. Microbiol. Rev. 2 315-328.
324. N. Crompton, B.M. Griffiths, M. Wilson, et al. (1999) The transfer of bacteria to, and survival on, dental records. Microbios 99 181-187.
325. A.S. Dajani, D.J. Law, R.O. Bollinger, et al. (1976) Ultrastructural and biochemical alterations effected by viridin B, a bacterocin of alpha-hemolytic streptococci. Infect. Immun. 14 776-782.
326. A.S. Dajani, K.A. Taubert, W. Wilson, et al. (1997) Prevention of bacterial endocarditis: Recommendations by the American Heart Association. Clin. Infect. Dis. 25 1448-1458.
327. A.S. Dajani, M.C. Tom and D.J. Law (1976) Viridins, bacteriocins of alpha-hemolytic streptococci: Isolation, characterization, and partial purification. Antimicrob. Agents Chemother. 9 81-88.
328. J.C. de Azavedo, L. Trpeski, S. Pong-Porter, et al. (1999) In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. Antimicrob. Agents Chemother. 43 2299-2301.
329. A.W. Dekker, M. Rozenberg-Arska and L.F. Verdonck (1990) Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment. Hamatol. Bluttransfusion 33 551-554.
330. C. Demers, M. Tremblay and Y. Lacourciere (1988) Acute vertebral osteomyelitis complicating Streptococcus sanguis endocarditis. Ann. Rheum. Dis. 47 333-336.
331. D.J. Diekema, M.L. Beach and M.A. Pfaller (2001) Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin. Microbiol. Infect. 7 152-157.
332. A. Docze, M. Mraz, E. Grey, et al. (2003) Penicillin resistance in viridans streptococcal bacteremia is related with high mortality. Scand. J. Infect. Dis. 35 916-917.
333. G.V. Doern, M.J. Ferraro, A.B. Brueggemann, et al. (1996) Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40 891-894.
334. E.C. Dompeling, J.P. Donnelly, J.M. Raemaekers, et al. (1994) Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine. Ann. Hematol. 69 69-71.
335. J.P. Donnelly, E.C. Dompeling, J.F. Meis, et al. (1995) Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: Cytostatics are a more important risk factor than antibacterial prophylaxis. Clin. Infect. Dis. 20 469-470.
336. C.W. Douglas, J. Heath, K.K. Hampton, et al. (1993) Identity of viridans streptococci isolated from cases of infective endocarditis. J. Med. Microbiol. 39 179-182.
337. C.G. Dowson, T.J. Coffey, C. Kell, et al. (1993) Evolution of penicillin resistance in Streptococcus pneumoniae: The role of Streptococcus mitis in the formation of a low-affinity PBP2B in S. pneumoniae. Mol. Microbiol. 9 635-643.
338. C.G. Dowson, A. Hutchison, N. Woodford, et al. (1990) Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 87 5858-5862.
339. R. Dwyer and S. Ringertz (1997) Viridans streptococci in blood cultures. Can we see any patterns of species related to patient category? Review of 229 cases of positive cultures with viridans streptococci. A. P. M. I. S. 105 972-974.
340. B.L. Edelstein (1994) The medical management of dental caries. J. Am. Dent. Assoc. 125(Suppl.), 31-39.
341. S. Edwardsson and B. Mejare (1978) Streptococcus milleri (Guthof) and Streptococcus mutans in the mouths of infants before and after tooth eruption. Arch. Oral Biol. 23 811-814.
342. R.H. Elliott and J.M. Dunbar (1977) Antibiotic sensitivity of oral alpha-haemolytic Streptococcus from children with congenital or acquired cardiac disease: A prolonged survey. Br. Dent. J. 142 283-285.
343. L.S. Elting, G.P. Bodey and B.H. Keefe (1992) Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors. Clin. Infect. Dis. 14 1201-1207.
344. L.S. Elting, E.B. Rubenstein, K.V.I. Rolston, et al. (1997) Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials. Clin. Infect. Dis. 25 247-259.
345. R.H. Eng, A.J. Mangia, S.M. Smith, et al. (1989) Meningitis following bacteremia with Streptococcus sanguis. N. Y. State J. Med. 89 625-626.
346. A. Engel, P. Kern and W.V. Kern (1996) Levels of cytokines and cytokine inhibitors in the neutropenic patient with alpha-hemolytic streptococcus shock syndrome. Clin. Infect. Dis. 23 785-789.
347. D. Engelhard, H. Elishoov, R. Or, et al. (1995) Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: A 5-year prospective study. Bone Marrow Transplant 16 565-570.
348. B.K. English, C.C. Patrick, S.L. Orlicek, et al. (1996) Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J. Infect. Dis. 174 1348-1351.
349. J.M. Entenza, I. Caldelari, M.P. Glauser, et al. (1997) Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii. J. Infect. Dis. 175 70-76.
350. R.H. Enting, J. de Gans, J.P. Blankevoort, et al. (1997) Meningitis due to viridans streptococci in adults. J. Neurol. 244 435-438.
351. P.R. Erickson and M.C. Herzberg (1999) Emergence of antibiotic resistant Streptococcus sanguis in dental plaque of children after frequent antibiotic therapy. Pediatr. Dent. 21 181-185.
352. N. Erverdi, T. Kadir, H. Ozkan, et al. (1999) Investigation of bacteremia after orthodontic banding. Am. J. Orthod. Dentofacial Orthop. 116 687-690.
353. R.R. Facklam (1977) Physiological differentiation of viridans streptococci. J. Clin. Microbiol. 5 184-201.
354. M.E. Falagas, D.K. Matthalou and I.A. Bliziotis (2006) The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: A meta-analysis of comparative trials. J. Antimicrob. Chemother. 57 639-647.
355. B.F. Farber, G.M. Eliopoulos, J.I. Ward, et al. (1983) Multiply resistant viridans streptococci: Susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns. Antimicrob. Agents Chemother. 24 702-705.
356. J.B. Fine, D.S. Harper, J.M. Gordon, et al. (1994) Short-term microbiological and clinical effects of subgingival irrigation with an antimicrobial mouthrinse. J. Periodontol. 65 30-36.
357. C.E. Flynn and K.L. Ruoff (1995) Identification of “ Streptococcus milleri” group isolates to the species level with a commercially available rapid test system. J. Clin. Microbiol. 33 2704-2706.
358. I. Ford, C.W. Douglas, F.E. Preston, et al. (1993) Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br. J. Haematol. 84 95-100.
359. J.M. Ford and R.E. DuBois (1984) Multiloculated hepatic abscess caused by alpha-hemolytic Streptococcus. South. Med. J. 77 514-516.
360. P.B. Francioli and M.P. Glauser (1993) Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 37 207-212.
361. E.V. Frandsen, V. Pedrazzoli and M. Kilian (1991) Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol. Immunol. 6 129-133.
362. J.J. Fraser Jr., M.I. Marks and D.F. Welch (1983) Neonatal sepsis and meningitis due to alpha-hemolytic Streptococcus. South. Med. J. 76 401-402.
363. R.M. Freedman and R. Baltimore (1990) Fatal Streptococcus viridans septicemia and meningitis: Relationship to fetal scalp electrode monitoring. J. Perinatol. 10 272-274.
364. M. Freitas, A. Casteio, G. Petty, et al. (2006) Viridans streptococci causing community acquired pneumonia. Arch. Dis. Child. 91 779-780.
365. I. Fujimori, K. Kikushima, K. Hisamatsu, et al. (1997) Interaction between oral alpha-streptococci and group A streptococci in patients with tonsillitis. Ann. Otol. Rhinol. Laryngol. 106 571-574.
366. F. Garnier, G. Gerbaud, P. Courvalin, et al. (1997) Identification of clinically relevant viridans group streptococci to the species level by PCR. J. Clin. Microbiol. 35 2337-2341.
367. A. Gassas, R. Grant, S. Richardson, et al. (2004) Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem cell transplant recipients. J. Clin. Oncol. 22 1222-1227.
368. S. George, A. Wadhera, K. Mersich, et al. (1996) Liver abscess due to Streptococcus sanguis. Clin. Infect. Dis. 22 191-192.
369. F. Ghaffar, I.R. Friedland, K. Katz, et al. (1999) Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J. Pediatr. 135 618-623.
370. M.P. Glauser and P. Francioli (1982) Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J. Infect. Dis. 146 806-810.
371. J. Goldfarb, G.P. Wormser and J.H. Glaser (1984) Meningitis caused by multiply antibiotic-resistant viridans streptococci. J. Pediatr. 105 891-895.
372. A. Goolam Mahomed, C. Feldman, C. Smith, et al. (1992) Does primary Streptococcus viridans pneumonia exist? S. Afr. Med. J. 82 432-434.
373. C.J. Graber, K.N. de Almeida, J.C. Atkinson, et al. (2001) Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27 537-542.
374. M. Grindefjord, G. Dahllof, S. Wikner, et al. (1991) Prevalence of mutans streptococci in one-year-old children. Oral Microbiol. Immunol. 6 280-283.
375. J.J. Groot-Loonen, J. van der Noordaa, J. de Kraker, et al. (1987) Alpha-hemolytic streptococcal septicemia with severe complications during neutropenia in childhood cancer. Pediatr. Hematol. Oncol. 4 323-328.
376. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. M. M. W. R. Recomm. Rep. 49(RR-10), 1-125.
377. H.F. Guiot, J.W. van der Meer, P.J. van den Broek, et al. (1992) Prevention of viridans-group streptococcal septicemia in oncohematologic patients: A controlled comparative study on the effect of penicillin G cotrimoxazole. Ann. Hematol. 64 260-265.
378. S. Hamada, N. Masuda and S. Kotani (1980) Isolation and serotyping of Streptococcus mutans from teeth and feces of children. J. Clin. Microbiol. 11 314-318.
379. X.Y. Han, M. Kamana and K.V. Rolston (2006) Viridans streptococci isolated by culture from blood of cancer patients: Clinical and microbiologic analysis of 50 cases. J. Clin. Microbiol. 44 160-165.
380. W.P. Hanage and J. Cohen (2002) Stimulation of cytokine release and adhesion molecule expression by products of viridans streptococci. J. Infect. Dis. 185 357-367.
381. M. Heiro, H. Helenius, S. Makila, et al. (2006) Infective endocarditis in a Finnish teaching hospital: A study on 326 episodes treated during 1980-2004. Heart 92 1457-1462.
382. J. Henslee, B. Bostrom, D. Weisdorf, et al. (1984) Streptococcal sepsis in bone marrow transplant patients. Lancet 1 393.
383. J. Hess, J. Dankert and D. Durack (1983) Significance of penicillin tolerance in vivo: Prevention of experimental Streptococcus sanguis endocarditis. J. Antimicrob. Chemother. 11 555-564.
384. Z. Hirschfeld, M. Friedman, G. Golomb, et al. (1984) New sustained release dosage form of chlorhexidine for dental use: Use for plaque control in partial denture wearers. J. Oral Rehabil. 11 477-482.
385. J.L. Hoecker, L.K. Pickering, D. Groschel, et al. (1978) Streptococcus salivarius sepsis in children with malignancies. J. Pediatr. 92 337-338.
386. S.D. Hogg and J.E. Manning (1988) Inhibition of adhesion of viridans streptococci to fibronectin-coated hydroxyapatite beads by lipoteichoic acid. J. Appl. Bacteriol. 65 483-489.
387. W.P. Holbrook, D. Olafsdottir, H.B. Magnusson, et al. (1988) Penicillin tolerance among oral streptococci. J. Med. Microbiol. 27 17-22.
388. H. Holmberg, D. Danielsson, J. Hardie, et al. (1985) Cross-reactions between alpha-streptococci and Omniserum, a polyvalent pneumococcal serum, demonstrated by direct immunofluorescence, immunoelectroosmophoresis, and latex agglutination. J. Clin. Microbiol. 21 745-748.
389. E.W. Hook III and M.A. Sande (1974) Role of the vegetation in experi-mental Streptococcus viridans endocarditis. Infect. Immun. 10 1433-1438.
390. R.B. Hsu and F.Y. Lin (2006) Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis. Cardiology 105 234-239.
391. S. Inoue, D. Boyer and R. Gordon (1990) Interstitial pneumonia and alpha-hemolytic Streptococcus sepsis in a child with malignancy who recently received cytosine arabinoside. Pediatr. Infect. Dis. J. 9 598-600.
392. D. Jaffe, A. Jakubowski, K. Sepkowitz, et al. (2004) Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: A single-center observational cohort study. Clin. Infect. Dis. 39 1625-1632.
393. J. James, T.W. MacFarlane, D.A. McGowan, et al. (1987) Failure of post-bacteraemia delayed antibiotic prophylaxis of experimental rabbit endocarditis. J. Antimicrob. Chemother. 20 883-885.
394. C. Janoir, I. Podglajen, M.D. Kitzis, et al. (1999) In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis. J. Infect. Dis. 180 555-558.
395. H. Jarvinen, J. Tenovuo and P. Huovinen (1993) In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents. Antimicrob. Agents Chemother. 37 1158-1159.
396. J.S. Jerng, P.R. Hsueh, L.J. Teng, et al. (1997) Empyema thoracis and lung abscess caused by viridans streptococci. Am. J. Respir. Crit. Care Med. 156 1508-1514.
397. M. Jonsson and G. Swedberg (2006) Macrolide resistance can be transferred by conjugation from viridans streptococci to Streptococcus pyogenes. Int. J. Antimicrob. Agents 28 101-103.
398. H.V. Jordan and P.F. De Paola (1974) Effect of a topically applied 3 percent vancomycin gel on Streptococcus mutans on different tooth surfaces. J. Dent. Res. 53 115-120.
399. A. Kaufhold and E. Potgieter (1993) Chromosomally mediated high-level gentamicin resistance in Streptococcus mitis. Antimicrob. Agents Chemother. 37 2740-2742.
400. Y. Kawamura, X.G. Hou, F. Sultana, et al. (1995) Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. nov. and Abiotrophia defectiva comb. nov., respectively. Int. J. Syst. Bacteriol. 45 798-803.
401. H.F. Kennedy, C.G. Gemmell, J. Bagg, et al. (2001) Antimicrobial susceptibility of blood culture isolates of viridans streptococci: Relationship to a change in empirical antibiotic therapy in febrile neutropenia. J. Antimicrob. Chemother. 47 693-696.
402. K.G. Kerr, H.T. Armitage and P.H. McWhinney (1999) Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy. Support Care Cancer 7 28-30.
403. K. Kikuchi, T. Enari, S. Minami, et al. (1994) Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis. J. Antimicrob. Chemother. 34 687-696.
404. R. Kilpper-Balz and K.-H. Schleifer (1988) Transfer of Streptococcus morbillorum to the genus Gemella as Gemella haemolysans. Int. J. Syst. Bacteriol. 38 442-443.
405. J. Klastersky (2003) Role of quinupristin/dalfopristin in the treatment of gram-positive nosocomial infections in haematological or oncological patients. Cancer Treat. Rev. 29 431-440.
406. S. Kontiainen and A. Sivonen (1987) Multiply resistant Streptococcus mitis isolated from conjunctival exudate of newborns. Eur. J. Clin. Microbiol. 6 53-55.
407. S. Kurland, E. Enghoff, J. Landelius, et al. (1999) A 10-year retrospective study of infective endocarditis at a university hospital with special regard to the timing of surgical evaluation in S. viridans endocarditis. Scand. J. Infect. Dis. 31 87-91.
408. T. Larsen and N.E. Fiehn (1996) Resistance of Streptococcus sanguis biofilms to antimicrobial agents. A. P. M. I. S. 104 280-284.
409. T. Leblanc, G. Leverger, G. Arlet, et al. (1989) Frequency and severity of systemic infections caused by Streptococcus mitis and sanguis II in neutropenic children. Pathol. Biol. (Paris) 37 459-464.
410. S.Y. Lee (2000) Postantibiotic effects and postantibiotic sub-MIC effects of amoxicillin on Streptococcus gordonii and Streptococcus sanguis. J. Chemother. 12 379-384.
411. E. Leviner, A.A. Tzukert, R. Benoliel, et al. (1987) Development of resistant oral viridans streptococci after administration of prophylactic antibiotics: Time management in the dental treatment of patients susceptible to infective endocarditis. Oral Surg. Oral Med. Oral Pathol. 64 417-420.
412. C.S. Levy, P. Kogulan, V.J. Gill, et al. (2001) Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin. Infect. Dis. 33 577-579.
413. L.D. Lilien, A.K. Wilks and T.F. Yeh (1982) Streptococcus sanguis biotype II meningitis in a premature infant. Clin. Pediatr. (Phila.) 21 465.
414. W.J. Loesche, A. Schork, M.S. Terpenning, et al. (1998) Assessing the relationship between dental disease and coronary heart disease in elderly U.S. veterans. J. Am. Dent. Assoc. 129 301-311.
415. J.H. Lowrance, L.M. Baddour and W.A. Simpson (1990) The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis. J. Clin. Invest. 86 7-13.
416. F.D. Lowy, D.S. Chang, E.G. Neuhaus, et al. (1983) Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis. J. Clin. Invest. 71 668-675.
417. C.H. Lu, W.N. Chang and H.W. Chang (2001) Adults with meningitis caused by viridans streptococci. Infection 29 305-309.
418. H.Z. Lu, X.H. Weng, B. Zhu, et al. (2003) Major outbreak of toxic shock–like syndrome caused by Streptococcus mitis. J. Clin. Microbiol. 41 3051-3055.
419. A. Macaluso, C. Simmang and T. Anthony (1998) Streptococcus sanguis bacteremia and colorectal cancer. South. Med. J. 91 206-207.
420. R. Malinverni, J. Bille and M.P. Glauser (1987) Single-dose rifampin prophylaxis for experimental endocarditis induced by high bacterial inocula of viridans streptococci. J. Infect. Dis. 156 151-157.
421. E. Malmberg, D. Birkhed, G. Norvenius, et al. (1994) Microorganisms on toothbrushes at day-care centers. Acta Odontol. Scand. 52 93-98.
422. J.E. Manning, E.B. Hume, N. Hunter, et al. (1994) An appraisal of the virulence factors associated with streptococcal endocarditis. J. Med. Microbiol. 40 110-114.
423. T.J. Marrie (1993) Bacteremic community-acquired pneumonia due to viridans group streptococci. Clin. Invest. Med. 16 38-44.
424. A. Marron, J. Carratala, F. Alcaide, et al. (2001) High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. J. Antimicrob. Chemother. 47 87-91.
425. A. Marron, J. Carratala, E. Gonzalez-Barca, et al. (2000) Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin. Infect. Dis. 31 1126-1130.
426. P.D. Marsh (1993) Antimicrobial strategies in the prevention of dental caries. Caries Res. 27(Suppl. 1), 72-76.
427. F. Martinez, F. Martin-Luengo, A. Garcia, et al. (1994) Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis. J. Antimicrob. Chemother. 33 1201-1207.
428. R. Martino, M. Subira, R. Manteiga, et al. (1995) Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: Comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation. Clin. Infect. Dis. 20 476-477.
429. K. Matsushita, W. Fujimaki, H. Kato, et al. (1995) Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect. Immun. 63 785-793.
430. M.E. McBride, W.C. Duncan and J.M. Knox (1980) Bacterial interference of Neisseria gonorrhoeae by alpha-haemolytic streptococci. Br. J. Vener. Dis. 56 235-238.
431. P.H. McWhinney, S.H. Gillespie, C.C. Kibbler, et al. (1991) Streptococcus mitis and ARDS in eutropenic patients. Lancet 337 429.
432. I.K. Mecrow and E.J. Ladusans (1994) Infective endocarditis in newborn infants with structurally normal hearts. Acta Paediatr. 83 35-39.
433. M.J. Meddens, J. Thompson, F. Eulderink, et al. (1982) Role of granulocytes in experimental Streptococcus sanguis endocarditis. Infect. Immun. 36 325-332.
434. M.J. Meddens, J. Thompson, H. Mattie, et al. (1984) Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits. Antimicrob. Agents Chemother. 25 263-267.
435. F. Menichetti, A. Del Favero, R. Guerciolini, et al. (1987) Viridans streptococci septicemia in cancer patients: A clinical study. Eur. J. Epidemiol. 3 316-318.
436. A.S. Mghir, A.C. Cremieux, R. Jambou, et al. (1994) Dextranase enhances antibiotic efficacy in experimental viridans streptococcal endocarditis. Antimicrob. Agents Chemother. 38 953-958.
437. S.M. Michalek, J.R. McGhee, J. Mestecky, et al. (1976) Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science 192 1238-1240.
438. R.S. Michel, E. DeFlora, J. Jefferies, et al. (1992) Recurrent meningitis in a child with inner ear dysplasia. Pediatr. Infect. Dis. J. 11 336-338.
439. A. Mogi, J.I. Nishi, M. Yoshinaga, et al. (1997) Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases. Pediatr. Infect. Dis. J. 16 1140-1144.
440. J.M. Molina, C. Leport, A. Bure, et al. (1991) Clinical and bacterial features of infections caused by Streptococcus milleri. Scand. J. Infect. Dis. 23 659-666.
441. K. Monefeldt, K. Helgeland and T. Tollefsen (1994) In vitro activation of the classical pathway of complement by a streptococcal lipoteichoic acid. Oral Microbiol. Immunol. 9 70-76.
442. A.S. Moomjian, M.M. Sokal and S. Vijayan (1984) Pathogenicity of alpha-hemolytic streptococci in the neonate. Am. J. Perinatol. 1 319-321.
443. I. Morisaki, J. Mihara, K. Kato, et al. (1990) Phenytoin-induced gingival overgrowth in rats infected with Streptococcus sobrinus 6715. Arch. Oral Biol. 35 753-758.
444. H.W. Murray, K.C. Gross, H. Masur, et al. (1978) Serious infections caused by Streptococcus milleri. Am. J. Med. 64 759-764.
445. C.M. Nascimento-Carvalho, M.C. Brandileone, M.L. Guerra, et al. (2001) Do viridans streptococci cause pneumonia in children? Pediatr. Infect. Dis. J. 20 726-728.
446. E. Newbrun (1992) Preventing dental caries: Breaking the chain of transmission. J. Am. Dent. Assoc. 123 55-59.
447. K.H. Ng, S. Lee, S.F. Yip, et al. (2005) A case of Streptococcus mitis endocarditis successfully treated by linezolid. Hong Kong Med. J. 11 411-413.
448. E.F. Ohuoba, R.G. Kansal, R.T. Hayden, et al. (2006) Failure of viridans group streptococci causing bacteremia in pediatric oncology patients to express superantigens. J. Pediatr. Hematol. Oncol. 28 627-629.
449. Y. Okamoto, R.C. Ribeiro, D.K. Srivastava, et al. (2003) Viridans streptococcal sepsis: Clinical features and complications in childhood acute myeloid leukemia. J. Pediatr. Hematol. Oncol. 25 696-703.
450. S.L. Orlicek, K.C. Branum, B.K. English, et al. (1997) Viridans streptococcal isolates from patients with septic shock induce tumor necrosis factor-alpha production by murine macrophages. J. Lab. Clin. Med. 130 515-519.
451. Y.P. Pan, Y. Li and P.W. Caufield (2001) Phenotypic and genotypic diversity of Streptococcus sanguis in infants. Oral Microbiol. Immunol. 16 235-242.
452. J.E. Parrillo, G.C. Borst, M.H. Mazur, et al. (1979) Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis. N. Engl. J. Med. 300 296-300.
453. L.C. Parrish, D.P. Kretzschmar and R.H. Swan (1989) Osteomyelitis associated with chronic periodontitis: A report of three cases. J. Periodontol. 60 716-722.
454. C. Pearce, G.H. Bowden, M. Evans, et al. (1995) Identification of pioneer viridans streptococci in the oral cavity of human neonates. J. Med. Microbiol. 42 67-72.
455. V. Peiris and B.A. Oppenheim (1993) Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures. J. Clin. Pathol. 46 1124-1125.
456. L. Persson, T. Vikerfors, L. Sjoberg, et al. (2000) Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia. Scand. J. Infect. Dis. 32 615-621.
457. E.M. Peterson, J.T. Shigei, A. Woolard, et al. (1988) Identification of viridans streptococci by three commercial systems. Am. J. Clin. Pathol. 90 87-91.
458. M.A. Pfaller and R.N. Jones (1997) In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci. Diagn. Microbiol. Infect. Dis. 27 151-154.
459. P.A. Pizzo, S. Ladisch and K. Ribichaud (1980) Treatment of gram-positive septicemia in cancer patients. Cancer 45 206-207.
460. P.A. Pizzo, S. Ladisch and F.G. Witebsky (1978) Alpha-hemolytic streptococci: Clinical significance in the cancer patient. Med. Pediatr. Oncol. 4 367-370.
461. P.M. Poole and G. Wilson (1977) Streptococcus milleri in the appendix. J. Clin. Pathol. 30 937-942.
462. E. Potgieter, M. Carmichael, H.J. Koornhof, et al. (1992) In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 11 543-546.
463. E. Potgieter and L.J. Chalkley (1991) Reciprocal transfer of penicillin resistance genes between Streptococcus pneumoniae Streptococcus mitior and Streptococcus sanguis. J. Antimicrob. Chemother. 28 463-465.
464. R.M. Prabhu, K.E. Piper, L.M. Baddour, et al. (2004) Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob. Agents Chemother. 48 4463-4465.
465. R.M. Prabhu, K.E. Piper, M.R. Litzow, et al. (2005) Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur. J. Clin. Microbiol. Infect. Dis. 24 832-838.
466. M.R. Pratter and R.S. Irwin (1980) Viridans streptococcal pulmonary parenchymal infections. J. A. M. A. 243 2515-2517.
467. L. Pulliam, L. Dall, S. Inokuchi, et al. (1985) Effects of exopolysaccharide production by viridans streptococci on penicillin therapy of experimental endocarditis. J. Infect. Dis. 151 153-156.
468. J.P. Quinn, C.A. DiVincenzo, D.A. Lucks, et al. (1988) Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J. Infect. Dis. 157 764-769.
469. K.B. Rapeport, J.A. Giron and F. Rosner (1986) Streptococcus mitis endocarditis: Report of 17 cases. Arch. Intern. Med. 146 2361-2363.
470. R.R. Razonable, M.R. Litzow, Y. Khaliq, et al. (2002) Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin. Infect. Dis. 34 1469-1474.
471. E. Reed, M. Arneson, W. Vaughan, et al. (1990) Streptococcus viridans (SV): A significant cause of neutropenic fever (NF) that caused death in some patients not empirically treated for gram-positive (GP) bacteria. Proc. Annu. Meet. Am. Soc. Clin. Oncol. 9 A1239.
472. B.S. Ribner and E.H. Freimer (1982) Osteomyelitis caused by viridans streptococci. Arch. Intern. Med. 142 1739.
473. P. Richard, G. Amador Del Valle, P. Moreau, et al. (1995) Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 345 1607-1609.
474. O. Ringden, A. Heimdahl, B. Lonnqvist, et al. (1984) Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1 744.
475. R.B. Roberts, A.G. Krieger, N.L. Schiller, et al. (1979) Viridans streptococcal endocarditis: The role of various species, including pyridoxal-dependent streptococci. Rev. Infect. Dis. 1 955-966.
476. K.V.I. Rolston, S. Frisbee-Hume, B. LeBlanc, et al. (2003) In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. Diagn. Microbiol. Infect. Dis. 47 441-449.
477. K.V.I. Rolston, I. Vaziri, S. Frisbee-Hume, et al. (2004) In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients. Chemotherapy 50 214-220.
478. K.V.I. Rolston, D. Yadegarynia, D.P. Kontoyiannis, et al. (2006) The spectrum of gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against gram-positive bacteria isolated from cancer patients. Int. J. Infect. Dis. 10 223-230.
479. K. Roos, S.E. Holm, E. Grahn, et al. (1993) Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: A randomized placebo-controlled study. Scand. J. Infect. Dis. 25 31-35.
480. K. Roos, S. Holm, E. Grahn-Hakansson, et al. (1996) Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis—a randomized placebo-controlled multicentre study. Scand. J. Infect. Dis. 28 459-462.
481. H.D. Rose (1981) Viridans streptococcal pneumonia. J. A. M. A. 245 32.
482. S.J. Rosser, M.J. Alfa, S. Hoban, et al. (1999) E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci. J. Clin. Microbiol. 37 26-30.
483. M. Rozenberg-Arska, A. Dekker, L. Verdonck, et al. (1989) Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin. Infection 17 240-244.
484. M. Rubin, J.W. Hathorn, D. Marshall, et al. (1988) Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann. Intern. Med. 108 30-35.
485. M.M. Rubin, R.J. Sanfilippo and R.S. Sadoff (1991) Vertebral osteomyelitis secondary to an oral infection. J. Oral Maxillofac. Surg. 49 897-900.
486. J.D. Rudney and C.J. Larson (1999) Identification of oral mitis group streptococci by arbitrarily primed polymerase chain reaction. Oral Microbiol. Immunol. 14 33-42.
487. K.L. Ruoff (1995) Streptococcus. P.R. Murray, E.J. Baron, M.A. Pfaller, et al., (Eds) Manual of Clinical Microbiology 6th ed. Washington, D.C.: American Society for Microbiology 299-307.
488. K.L. Ruoff and L.J. Kunz (1982) Identification of viridans streptococci isolated from clinical specimens. J. Clin. Microbiol. 15 920-925.
489. K.L. Ruoff and L.J. Kunz (1983) Use of the Rapid STREP system for identification of viridans streptococcal species. J. Clin. Microbiol. 18 1138-1140.
490. M. Saarela, B. von Troil-Linden, H. Torkko, et al. (1993) Transmission of oral bacterial species between spouses. Oral Microbiol. Immunol. 8 349-354.
491. H.S. Sader, J.M. Streit, T.R. Fritsche, et al. (2006) Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: Results of the Daptomycin Surveillance Programme (2002-2004). Clin. Microbiol. Infect. 12 844-852.
492. M. Salavert, L. Gomez, M. Rodriguez-Carballeira, et al. (1996) Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur. J. Clin. Microbiol. Infect. Dis. 15 365-371.
493. J.T. Sandlund, S.C. Howard, N. Hijiya, et al. (2005) Myositis complicating viridans streptococcal sepsis in childhood leukemia. Pediatr. Blood Cancer 44 277-279.
494. T.K. Sarkar, R.S. Murarka and G.L. Gilardi (1989) Primary Streptococcus viridans pneumonia. Chest 96 831-834.
495. F.J. Schmitz, A. Fisher, M. Boos, et al. (2001) Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis Streptococcus sanguis, and Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 20 219-222.
496. P.M. Schneeberger, M. Janssen and A. Voss (1996) Alpha-hemolytic streptococci: A major pathogen of iatrogenic meningitis following lumbar puncture. Case reports and a review of the literature. Infection 24 29-33.
497. J. Schollin (1988) Adherence of alpha-hemolytic streptococci to human endocardial, endothelial and buccal cells. Acta Paediatr. Scand. 77 705-710.
498. J. Schollin and D. Danielsson (1988) Bacterial adherence to endothelial cells from rat heart, with special regard to alpha-hemolytic streptococci. A. P. M. I. S. 96 428-432.
499. D.C. Shanson, F.D. Thomas and D. Johnstone (1985) Improving detection of “viridans Streptococcus” bacteraemia by adding sodium polyanethol sulphonate to blood cultures. J. Clin. Pathol. 38 1346-1348.
500. D.C. Shanson, F. Thomas and D. Wilson (1984) Effect of volume of blood cultured on detection of Streptococcus viridans bacteraemia. J. Clin. Pathol. 37 568-570.
501. J.H. Shaw (1987) Causes and control of dental caries. N. Engl. J. Med. 317 996-1004.
502. S.A. Shelburne 3rd., S.B. Greenberg, S. Aslam, et al. (2007) Success ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci. J. Infect. 54 e99-e101.
503. J.L. Shenep, W.T. Hughes, P.K. Roberson, et al. (1988) Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N. Engl. J. Med. 319 1053-1058.
504. A.M. Shibl (1985) Effect of antibiotics on adherence of microorganisms to epithelial cell surfaces. Rev. Infect. Dis. 7 51-65.
505. D.M. Shlaes, J. Marino and M.R. Jacobs (1984) Infection caused by vancomycin-resistant Streptococcus sanguis II. Antimicrob. Agents Chemother. 25 527-528.
506. S.T. Shulman (1993) Streptococcus viridans—not!. Am. J. Dis. Child. 47 611.
507. D.J. Smith, J.M. Anderson, W.F. King, et al. (1993) Oral streptococcal colonization of infants. Oral Microbiol. Immunol. 8 1-4.
508. M. Soell, F. Holveck, M. Scholler, et al. (1994) Binding of Streptococcus mutans SR protein to human monocytes: Production of tumor necrosis factor, interleukin 1, and interleukin 6. Infect. Immun. 62 1805-1812.
509. S.V. Sotiropoulos, M.A. Jackson, G.M. Woods, et al. (1989) Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr. Infect. Dis. J. 8 755-758.
510. A. Soto, T.J. Evans and J. Cohen (1996) Proinflammatory cytokine production by human peripheral blood mononuclear cells stimulated with cell-free supernatants of viridans streptococci. Cytokine 8 300-304.
511. A. Soto, P.H. McWhinney, C.C. Kibbler, et al. (1998) Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome. Cytokine 10 370-376.
512. S. Spanik, J. Trupl, A. Kunova, et al. (1997) Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: Analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand. J. Infect. Dis. 29 245-249.
513. W.T. Speck, S.S. Spear, E. Krongrad, et al. (1976) Transient bacteremia in pediatric patients after dental extraction. Am. J. Dis. Child. 130 406-407.
514. K. Sprunt, W. Redman and G. Leidy (1968) Penicillin-resistant alpha streptococci in pharynx of patients given oral penicillin. Pediatrics 42 957-968.
515. E. Staves and N. Tinanoff (1991) Decline in salivary S. mutans levels in children who have received short-term antibiotic therapy. Pediatr. Dent. 13 176-178.
516. M. Steiner, J. Villablanca, J. Kersey, et al. (1993) Viridans streptococcal shock in bone marrow transplantation patients. Am. J. Hematol. 42 354-358.
517. H.M. Stimmel, J.J. Orchen, D.M. Skaff, et al. (1981) Penicillin-resistant alpha-hemolytic streptococci in children with heart disease who take penicillin daily. A. S. D. C. J. Dent. Child. 48 29-32.
518. P.M. Sullam, U. Frank, M.R. Yeaman, et al. (1993) Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect. Dis. 168 910-914.
519. J.I. Sussman, E.J. Baron, M.J. Tenenbaum, et al. (1986) Viridans streptococcal endocarditis: Clinical, microbiological, and echocardiographic correlations. J. Infect. Dis. 154 597-603.
520. L.B. Svinhufvud, A. Heimdahl and C.E. Nord (1988) Effect of topical administration of vancomycin versus chlorhexidine on alpha-hemolytic streptococci in oral cavity. Oral Med. 66 304-309.
521. H. Takada, Y. Kawabata, M. Tamura, et al. (1993) Cytokine induction by extracellular products of oral viridans group streptococci. Infect. Immun. 61 5252-5260.
522. N. Takahashi, M. Horiuchi and T. Yamada (1997) Effects of acidification on growth and glycolysis of Streptococcus sanguis and Streptococcus mutans. Oral Microbiol. Immunol. 12 72-76.
523. K. Tano, C. Olofsson, E. Grahn-Hakansson, et al. (1999) In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catarrhalis by alpha-hemolytic streptococci from healthy children. Int. J. Pediatr. Otorhinolaryngol. 47 49-56.
524. A.R. Tappuni and S.J. Challacombe (1993) Distribution and isolation frequency of eight streptococcal species in saliva from predentate and dentate children and adults. J. Dent. Res. 72 31-36.
525. T. Tasaka, M. Nagai, K. Sasaki, et al. (1993) Streptococcus mitis septicemia in leukemia patients: Clinical features and outcome. Intern. Med. 32 221-224.
526. E.A. Thibodeau and D.M. O'Sullivan (1995) Salivary mutans streptococci and incidence of caries in preschool children. Caries Res. 29 148-153.
527. L. Thorig, M.R. Daha, F. Eulderink, et al. (1980) Experimental Streptococcus sanguis endocarditis: Immune complexes and renal involvement. Clin. Exp. Immunol. 40 469-477.
528. G.J. Timmers, Y. Dijstelbloem, A.M. Simoons-Smit, et al. (2004) Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies. Bone Marrow Transplant 33 847-853.
529. G.J. Timmers, A.M. Simoons-Smit, M.E. Leidekker, et al. (2007) Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. Clin. Microbiol. Infect. 13 497-503.
530. N. Tinanoff (1990) Review of the antimicrobial action of stannous fluoride. J. Clin. Dent. 2 22-27.
531. I.M. Tleyjeh, J.M. Steckelberg, H.S. Murad, et al. (2005) Temporal trends in infective endocarditis: A population-based study in Olmsted County, Minnesota. J. A. M. A. 293 3022-3028.
532. D.C. Tong and B.R. Rothwell (2000) Antibiotic prophylaxis in dentistry: A review and practice recommendations. J. Am. Dent. Assoc. 131 366-374.
533. A.R. Tunkel and K.A. Sepkowitz (2002) Infections caused by viridans streptococci in patients with neutropenia. Clin. Infect. Dis. 34 1524-1529.
534. M. Tuohy and J.A. Washington (1997) Antimicrobial susceptibility of viridans group streptococci. Diagn. Microbiol. Infect. Dis. 29 277-280.
535. S. Twetman, A. Mattiasson, J.R. Varela, et al. (1990) Mutans streptococci in saliva and dental caries in children living in a high and a low fluoride area. Oral Microbiol. Immunol. 5 169-171.
536. Y. Uehara, K. Agematsu, K. Kikuchi, et al. (2006) Secretory IgA, salivary peroxidase, and catalase-mediated microbicidal activity during hydrogen peroxide catabolism in viridans streptococci: Pathogen coaggregation. J. Infect. Dis. 194 98-107.
537. Y. Uehara, K. Kikuchi, T. Nakamura, et al. (2001) Inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns by viridans group streptococci. Clin. Infect. Dis. 32 1399-1407.
538. Y. Uehara, K. Kikuchi, T. Nakamura, et al. (2001) H 2O 2 produced by viridans group streptococci may contribute to inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns. Clin. Infect. Dis. 32 1408-1413.
539. R.F. Ullman, M.J. Strampfer and B.A. Cunha (1988) Streptococcus mutans vertebral osteomyelitis. Heart Lung 17 319-321.
540. B.N. Ullsfoss, B. Ogaard, J. Arends, et al. (1994) Effect of a combined chlorhexidine and NaF mouthrinse: An in vivo human caries model study. Scand. J. Dent. Res. 102 109-112.
541. J. van Houte (1983) Bacterial adherence in the mouth. Rev. Infect. Dis. 5(Suppl. 4), 659-669.
542. J. van Houte (1994) Role of micro-organisms in caries etiology. J. Dent. Res. 73 672-681.
543. C. van Loveren, J.F. Buijs and J.M. ten Cate (2000) Similarity of bacteriocin activity profiles of mutans streptococci within the family when the children acquire the strains after the age of 5. Caries Res. 34 481-485.
544. C. van Loveren, Y.M. Van de Plassche-Simons, J.J. De Soet, et al. (1991) Acidogenesis in relation to fluoride resistance of Streptococcus mutans. Oral Microbiol. Immunol. 6 288-291.
545. A. Vernier, M. Diab, M. Soell, et al. (1996) Cytokine production by human epithelial and endothelial cells following exposure to oral viridans streptococci involves lectin interactions between bacteria and cell surface receptors. Infect. Immun. 64 3016-3022.
546. A. Vernier-Georgenthum, S. al-Okla, B. Gourieux, et al. (1998) Protein I/II of oral viridans streptococci increases expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Cell. Immunol. 187 145-150.
547. M.V. Vicente, T. Olay and A. Rodriguez (1981) Experimental endocarditis caused by Streptococcus sanguis: Single and combined antibiotic therapy. Antimicrob. Agents Chemother. 20 10-14.
548. A. Wanahita, E.A. Goldsmith, D.M. Musher, et al. (2002) Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria. J. Infect. Dis. 185 85-90.
549. C. Watanakunakorn and J. Pantelakis (1993) Alpha-hemolytic streptococcal bacteremia: A review of 203 episodes during 1980-1991. Scand. J. Infect. Dis. 25 403-408.
550. M. Weber, J. Gubler, H. Fahrer, et al. (1999) Spondylodiscitis caused by viridans streptococci: Three cases and a review of the literature. Clin. Rheumatol. 18 417-421.
551. S.J. Weinberger and G.Z. Wright (1990) A comparison of S. mutans clinical assessment methods. Pediatr. Dent. 12 375-379.
552. P.W. West, R. Al-Sawan, H.A. Foster, et al. (1998) Speciation of presumptive viridans streptococci from early onset neonatal sepsis. J. Med. Microbiol. 47 923-928.
553. K. Westling, I. Julander, P. Ljungman, et al. (2006) Viridans group streptococci in blood culture isolates in a Swedish university hospital: Antibiotic susceptibility and identification of erythromycin resistance genes. Int. J. Antimicrob. Agents 28 292-296.
554. K. Westling, P. Ljungman, A. Thalme, et al. (2002) Streptococcus viridans septicaemia: A comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital. Scand. J. Infect. Dis. 34 316-319.
555. M.H. Wilcox, T.G. Winstanley, C.W. Douglas, et al. (1993) Susceptibility of alpha-haemolytic streptococci causing endocarditis to benzylpenicillin and ten cephalosporins. J. Antimicrob. Chemother. 32 63-69.
556. A.P. Wilson and H. Gaya (1996) Treatment of endocarditis with teicoplanin: A retrospective analysis of 104 cases. J. Antimicrob. Chemother. 38 507-521.
557. M. Wilson, H. Patel and J. Fletcher (1996) Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chloride. Oral Microbiol. Immunol. 11 188-192.
558. H. Wisplinghoff, R.R. Reinert, O. Cornely, et al. (1999) Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J. Clin. Microbiol. 37 1876-1880.
559. L.G. Yaniv and I. Potasman (2000) Iatrogenic meningitis: An increasing role for resistant viridans streptococci?. Case report and review of the last 20 years. Scand. J. Infect. Dis. 32 693-696.
560. R.L. Yap, L.A. Mermel and J. Maglio (2006) Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci. Infection 34 339-341.
561. Y. Yee, B. Farber and S. Mates (1986) Mechanism of penicillin-streptomycin synergy for clinical isolates of viridans streptococci. J. Infect. Dis. 154 531-534.
562. I. Zickert, C.G. Emilson, K. Ekblom, et al. (1987) Prolonged oral reduction of Streptococcus mutans in humans after chlorhexidine disinfection followed by fluoride treatment. Scand. J. Dent. Res. 95 315-319.
563. E.T. Zito and L. Daneo-Moore (1988) Transformation of Streptococcus sanguis to intrinsic penicillin resistance. J. Gen. Microbiol. 134 1237-1249.
564. G. Zuccaro, J.E. Richter, T.W. Rice, et al. (1998) Viridans streptococcal bacteremia after esophageal stricture dilation. Gastrointest. Endosc. 48 568-573.